Marco Pistis Selected Research

Marco Pistis Research Topics

Disease

10	Schizophrenia (Dementia Praecox) 12/2023 - 11/2004
7	Tobacco Use Disorder (Nicotine Dependence) 01/2020 - 12/2008
6	Mental Disorders (Mental Disorder) 01/2022 - 01/2016
5	Substance-Related Disorders (Drug Abuse) 01/2020 - 12/2012
3	Neuroinflammatory Diseases 01/2023 - 10/2021
3	Cognitive Dysfunction 01/2022 - 01/2015
3	Psychotic Disorders (Schizoaffective Disorder) 01/2019 - 01/2016
2	Dyslipidemias (Dyslipidemia) 12/2022 - 10/2021
2	COVID-19 11/2022 - 01/2021
2	Fatty Liver 01/2022 - 10/2021
2	Pain (Aches) 10/2021 - 10/2015
2	Virus Diseases (Viral Diseases) 01/2019 - 01/2016
2	Seizures (Absence Seizure) 10/2017 - 01/2013
2	Alcoholism (Alcohol Abuse) 03/2008 - 12/2005
1	Drug Resistant Epilepsy 11/2023
1	Inflammation (Inflammations) 01/2023
1	Body Weight (Weight, Body) 12/2022
1	Weight Gain 12/2022
1	Neurobehavioral Manifestations 01/2022
1	Gliosis 01/2021
1	Narcolepsy 01/2020
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2019
1	Sudden Infant Death (SID) 03/2019
1	Autosomal Dominant Nocturnal Frontal Lobe Epilepsy 10/2017
1	Frontal Lobe Epilepsy (Epilepsy, Supplementary Motor) 10/2017
1	Anhedonia 11/2016
1	Depressive Disorder (Melancholia) 11/2016
1	Marijuana Abuse (Cannabis Abuse) 04/2016
1	Peripheral Nerve Injuries 10/2015
1	Neuralgia (Stump Neuralgia) 10/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2015
1	Parkinson Disease (Parkinson's Disease) 01/2015
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2013
1	Epilepsy (Aura) 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2012
1	Gambling (Pathological Gambling) 07/2010
1	Ischemia 10/2006
1	Bone Resorption 06/2002

Drug/Important Bio-Agent (IBA)

15	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 10/2006
14	EndocannabinoidsIBA 01/2023 - 11/2004
5	Fenofibrate (CiL)FDA LinkGeneric 12/2023 - 01/2013
5	LipidsIBA 12/2022 - 12/2008
4	Nicotine FDA Link 01/2019 - 07/2012
3	Dronabinol (THC)FDA LinkGeneric 01/2023 - 11/2013
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2022 - 08/2014
3	LigandsIBA 12/2022 - 12/2008
3	AcidsIBA 01/2022 - 01/2016
3	PPAR alphaIBA 01/2019 - 12/2008
3	CannabinoidsIBA 01/2019 - 11/2013
2	CytokinesIBA 12/2023 - 01/2023
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020 - 01/2016
2	SmokeIBA 03/2019 - 01/2019
1	Biomarkers (Surrogate Marker)IBA 11/2023
1	CalciumIBA 01/2023
1	EnzymesIBA 01/2023
1	Antipsychotic Agents (Antipsychotics)IBA 01/2023
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2023
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2022
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2022
1	VaccinesIBA 11/2022
1	alpha-SynucleinIBA 01/2022
1	Conjugated Linoleic AcidsIBA 01/2022
1	N-acylethanolaminesIBA 01/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022
1	Docosahexaenoic AcidsIBA 01/2022
1	Dehydroepiandrosterone (DHEA)IBA 01/2022
1	Opioid Analgesics (Opioids)IBA 10/2021
1	Morphine (MS Contin)FDA LinkGeneric 10/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	KynurenineIBA 05/2019
1	Poly I-CIBA 01/2019
1	Cocaine (Cocaine HCl)IBA 01/2019
1	Antidepressive Agents (Antidepressants)IBA 11/2016
1	Sucrose (Saccharose)IBA 11/2016
1	Cholinergic Agents (Cholinergics)IBA 01/2016
1	Serotonin (5 Hydroxytryptamine)IBA 10/2015
1	salicylhydroxamic acid (SHAM)IBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	Ro 61-8048IBA 11/2013
1	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 11/2013
1	Fibric Acids (Fibrates)IBA 07/2012
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 10/2006
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 10/2006
1	LDL CholesterolIBA 06/2002
1	CholesterolIBA 06/2002
1	Insulin (Novolin)FDA Link 06/2002
1	pyridinolineIBA 06/2002

Therapy/Procedure

5	Therapeutics 11/2023 - 12/2005
2	Self Administration (Administration, Self) 04/2016 - 11/2013
1	Vagus Nerve Stimulation 11/2023
1	Secondary Prevention 01/2016